Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 3,265,689 | $398,186 | — | — |
| Q3 2025 | 13,538,738 | $1,356,582 | — | — |
| Q2 2025 | 10,638,105 | $882,218 | — | — |
| Q1 2025 | 10,369,706 | $840,983 | — | — |
| Q4 2024 | 8,008,848 | $721,277 | — | — |
| Q3 2024 | 12,275,585 | $1,212,828 | — | — |
| Q2 2024 | 12,325,290 | $1,142,678 | — | — |
| Q1 2024 | 7,845,847 | $744,492 | — | — |
| Q4 2023 | 4,098,441 | $365,950 | — | — |
| Q3 2023 | 4,878,925 | $356,259 | — | — |
| Q2 2023 | 5,084,252 | $423,010 | — | — |
| Q1 2023 | 7,534,471 | $574,202 | — | — |
| Q4 2022 | 2,699,400 | $224 | — | — |
| Q3 2022 | 2,536,595 | $201,202 | — | — |
| Q2 2022 | 714,036 | $53,032 | — | — |
| Q1 2022 | 457,384 | $41,110 | — | — |
| Q4 2021 | 217,986 | $24,406 | — | — |
| Q3 2021 | 2,640,450 | $331,930 | — | — |
| Q2 2021 | 4,552,548 | $616,415 | — | — |
| Q1 2021 | 6,792,579 | $921,413 | — | — |
| Q4 2020 | 967,287 | $136,175 | — | — |
| Q3 2020 | 10,539,489 | $1,177,155 | — | — |
| Q2 2020 | 10,575,344 | $1,183,911 | — | — |
| Q1 2020 | 9,853,687 | $763,069 | — | — |
| Q4 2019 | 101,592 | $9,662 | — | — |
| Q3 2019 | 6,621,352 | $504,878 | — | — |
| Q2 2019 | 3,973,227 | $341,499 | — | — |
| Q1 2019 | 4,761,913 | $431,143 | — | — |
| Q4 2018 | 3,041,658 | $218,239 | — | — |
| Q3 2018 | 3,265,715 | $313,084 | — | — |
| Q2 2018 | 1,643,343 | $156,430 | — | — |
| Q1 2018 | 1,462,600 | $128,314 | — | — |
| Q4 2017 | 889,169 | $75,464 | — | — |
| Q3 2017 | 2,028,544 | $174,211 | — | — |
| Q2 2017 | 3,032,849 | $234,075 | — | — |
| Q1 2017 | 3,379,694 | $234,348 | — | — |
| Q4 2016 | 1,149,802 | $68,057 | — | — |
| Q3 2016 | 712,986 | $47,264 | — | — |
| Q2 2016 | 2,346,223 | $126,907 | — | — |
| Q1 2016 | 3,109,212 | $160,622 | — | — |
| Q4 2015 | 3,921,421 | $274,813 | — | — |
| Q3 2015 | 3,918,923 | $243,953 | — | — |
| Q2 2015 | 1,424,505 | $359,317 | — | — |
| Q1 2015 | 1,245,841 | $280,937 | — | — |
| Q4 2014 | 2,152,927 | $401,434 | — | — |
| Q3 2014 | 2,250,292 | $350,979 | — | — |
| Q2 2014 | 2,150,000 | $331,079 | — | — |
| Q1 2014 | 2,252,094 | $320,878 | — | — |
| Q4 2013 | 2,251,322 | $293,122 | — | — |
| Q3 2013 | 2,451,447 | $316,629 | — | — |
| Q2 2013 | 2,200,039 | $229,376 | — | — |